PPAR ligands decrease human airway smooth muscle cell migration and extracellular matrix synthesis Source: Eur Respir J 2013; 41: 425-432 Year: 2013
PPAR-γ agonists as therapy for diseases involving airway neutrophilia Source: Eur Respir J 2004; 24: 18-23 Year: 2004
Differential regulation of neurotrophin expression in human airway smooth muscle cells by pro-inflammatory cytokines Source: Eur Respir J 2002; 20: Suppl. 38, 383s Year: 2002
Endothelin receptor B protects GM-CSF mRNA from degradation in human airway smooth muscle cells Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015
Protein kinase C and MAPK pathways transcriptionally regulate eotaxin release from human airway smooth muscle cells (HASMC) Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions Year: 2005
Sphingosine-1-phosphate receptor expression and signalling in human airway smooth muscle cells Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011
Role of NF-?B and PPAR-? in lung inflammation induced by monocyte-derived microparticles Source: Eur Respir J 2011; 37: 1494-1502 Year: 2011
Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
Peroxisome proliferator activated receptor gamma (PPARγ) agonist rosiglitizone inhibits upregulation of mucin gene expression in two airway epithelial cell lines Source: Eur Respir J 2005; 26: Suppl. 49, 97s Year: 2005
RANTES expression induced by Toll-like receptor 3 and 4 ligands on rat airway smooth muscle cells Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009
Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD Source: Eur Respir J 2007; 30: 245-252 Year: 2007
Evidence for potential autocrine regulation of human airway smooth muscle cell functions by neurokinins: modulation of gene expression by glucocorticoids Source: Eur Respir J 2003; 22: Suppl. 45, 11s Year: 2003
The perxisome proliferator-activated receptor gamma agonist, rosiglitazone, inhibits IL-8 synthesis by airway epithelial cells stimulated with monocyte-derived microparticles Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007
Activation of airway epithelial cell inhibited by peroxisome proliferator-activated receptor γ Source: Eur Respir J 2006; 28: Suppl. 50, 229s Year: 2006
Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Source: Eur Respir J 2008; 31: 502-508 Year: 2008
Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells Source: Eur Respir J 2009; 34: 1436-1443 Year: 2009
The effects of exercise training on peroxisome proliferator-activated receptor (PPAR) expression in skeletal muscle in COPD Source: Annual Congress 2009 - Emerging physiology behind pulmonary rehabilitation Year: 2009
TLR3/TAK1 signalling regulates rhinovirus-induced interleukin-33 in bronchial smooth muscle cells Source: ERJ Open Res, 6 (4) 00147-2020; 10.1183/23120541.00147-2020 Year: 2020
Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions Year: 2005
CRE, but not AP-1, NF-κB, or C/EBP, mediates β-agonist-induced IL-6 gene expression induced in human airway smooth muscle (HASM) cells Source: Eur Respir J 2001; 18: Suppl. 33, 407s Year: 2001